Healthcare stock checkup: Are Redcare Pharmacy & Gerresheimer now a buy after a decline of up to 60.9%?
Redcare Pharmacy and Gerresheimer shares have recently fallen sharply. What is their future prospects?
Summarized for you
Redcare Pharmacy shares have already lost more than 45 percent of their value since November 2024, even though the company is benefiting from the megatrend of telemedicine and the associated cost savings in the healthcare system (June 12, 2025).
But what are the causes?
Advertisement Presented by
Long
Short
wallstreetONLINE Editorial Team
0 followersShow more
Show more
Written by 
Christof Welzel
wallstreet-online
